Signal active
Bio
Mr. Galbraith joined Ventures West in 2007 and leads the firm's biotech practice. Mr. Galbraith is a well-known and active member of the North American life sciences community with over 20 years of experience acting as an executive, director, investor and advisor to companies in the biotechnology, medical device, pharmaceutical and healthcare sectors. In 2006, Mr. Galbraith served as the Chairman and Interim CEO of AnorMED, a biopharmaceutical company focused on new therapeutic products in hematology, HIV and oncology, until its sale to Genzyme Corp. in a cash transaction worth almost $600 million. Previously, Mr. Galbraith spent 13 years in senior management with QLT Inc., a global biopharmaceutical company specializing in developing treatments for eye diseases and oncology, retiring in 2000 from his position as Executive VP and CFO. He currently serves as a Director of Alder Biopharmaceuticals, Aquinox Pharmaceuticals, Celator Pharmaceuticals, MacroGenics, NeurAxon and Presidio Pharmaceuticals.
Location
Vancouver, British Columbia, Canada, North America
Social
Primary Organization
2008
101-250
Health Care, Medical Device, Health Diagnostics
Jobs history
4
Zymeworks
Chair & Chief Executive Officer
2022 - Current
Chair
2021 - Current
Profound Medical Inc
Corporate Director
2017 - Current
Liminal BioSciences
CEO
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Kenneth Galbraith is the Corporate Director at Profound Medical Inc, based in North America. With a background in Health Care, Kenneth Galbraith has a rich history of leadership and innovation. Kenneth Galbraith studied B.Com unknown @ University of British Columbia. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
13
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Sep 01, 2010 | Celator Pharmaceuticals | Series D - Celator Pharmaceuticals | Ventures West | 20.0M |
Sep 30, 2010 | NeurAxon | Debt Financing - NeurAxon | Ventures West | 14.0M |
Apr 19, 2012 | Alder Biopharmaceuticals | Series D - Alder Biopharmaceuticals | Ventures West | 38.0M |
Apr 03, 2013 | Aquinox Pharmaceuticals | Series C - Aquinox Pharmaceuticals | Ventures West | 18.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.